Grant: CIHR Fellowship
McMaster University
$90,000.00
Horizontal transfer of antibiotic resistance in polymicrobial communities
FY 2010-11
Summary
Antibiotics like penicillin are often thought of as 'miracle drugs' that are able to cure all infectious disease. However, many of the antibiotics we used 10 years ago are no longer effective against the bacteria that threaten human health today. When a bacterium is not killed by a particular antibiotic, it is said to be 'resistant' to that antibiotic (i.e. the antibiotic is no longer effective as a medical solution). Most antibiotic resistance happens when bacteria pick up DNA carrying antibiotic resistance genes from other bacteria living in the same environment. We know this happens often in hospitals, where 'superbugs' like methicillin-resistant Staphylococcus aureus (known as MRSA) have become a global health problem. But where do antibiotic resistance genes come from in the first place?
While some bacteria cause infections in animals and people, most bacteria are completely harmless, and some are even useful; for example, many bacteria found in the soil are used to manufacture the antibiotics which are currently prescribed to fight human infections. Since bacteria in the soil live in large communitites with other bacteria, they are often exposed to the antibiotics their neighbours produce. As a result, many have evolved resistance to antibiotics long before those drugs are used therapeutically in hospitals.
Our lab has previously shown that antibiotic resistance genes are widespread in soil bacteria. However, there is no research to date to show how these genes end up in bacteria that cause disease. Our goal is to track the spread of resistance genes to the antibiotic erythromycin from soil bacteria to bacteria that cause disease in people like Acinetobacter baumannii. This project is important for the health of Canadians, since if we know where antibiotic resistance genes come from, we may be albe to predict what bacteria will next become resistant and design antibiotics that are more effective in the future.
Department
Program
CIHR Fellowship
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
214379
Name
Perry Julie A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Horizontal transfer of antibiotic resistance in polymicrobial communities
Programtype2
Fellowship Programs
Orgnameinp2
McMaster University
Cihramount2
$90,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Antibiotic Resistance; Evolution; Genetics; Horizontal Gene Transfer; Micro-Droplet Pcr; Next-Generation Sequencing; Soil Microbiology
Abstract
Antibiotics like penicillin are often thought of as 'miracle drugs' that are able to cure all infectious disease. However, many of the antibiotics we used 10 years ago are no longer effective against the bacteria that threaten human health today. When a bacterium is not killed by a particular antibiotic, it is said to be 'resistant' to that antibiotic (i.e. the antibiotic is no longer effective as a medical solution). Most antibiotic resistance happens when bacteria pick up DNA carrying antibiotic resistance genes from other bacteria living in the same environment. We know this happens often in hospitals, where 'superbugs' like methicillin-resistant Staphylococcus aureus (known as MRSA) have become a global health problem. But where do antibiotic resistance genes come from in the first place?
While some bacteria cause infections in animals and people, most bacteria are completely harmless, and some are even useful; for example, many bacteria found in the soil are used to manufacture the antibiotics which are currently prescribed to fight human infections. Since bacteria in the soil live in large communitites with other bacteria, they are often exposed to the antibiotics their neighbours produce. As a result, many have evolved resistance to antibiotics long before those drugs are used therapeutically in hospitals.
Our lab has previously shown that antibiotic resistance genes are widespread in soil bacteria. However, there is no research to date to show how these genes end up in bacteria that cause disease. Our goal is to track the spread of resistance genes to the antibiotic erythromycin from soil bacteria to bacteria that cause disease in people like Acinetobacter baumannii. This project is important for the health of Canadians, since if we know where antibiotic resistance genes come from, we may be albe to predict what bacteria will next become resistant and design antibiotics that are more effective in the future.
Competitiondate
201010
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Perry, Julie A
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $90,000~ $0~